Drawing for RHB PART

USPTO serial 79358374

RHB PART

Reviewed by CopyMark Law Group

Reg. 7821159Status 700Registered
Filing date
Status date
Registration date
Jun 10, 2025
Examiner
LAVACHE, LINDA M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RHB PART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for industrial use in manufacture; biological preparations for use in industry; nucleic recombinant acids, other than for medical and veterinary purposesACTIVE
005Biotechnological preparations for medical use for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations for medical purposes for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations, namely, nucleic recombinant acids for medical useACTIVE
042Biotechnological research; testing of biological reagents for use in molecular biologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 22, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 7, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 7, 2026FIMPFINAL DISPOSITION PROCESSED
Sep 10, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 10, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 30, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2024GPNXNOTIFICATION PROCESSED BY IB
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2024XAECEXAMINER'S AMENDMENT ENTERED
Apr 18, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Apr 18, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 1, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Feb 1, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 1, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2023RFNTREFUSAL PROCESSED BY IB
Jul 6, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2023RFRRREFUSAL PROCESSED BY MPU
May 26, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 25, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2023DOCKASSIGNED TO EXAMINER
Dec 31, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance